Oocyte Donation From Donor Older Than 35 Years. Is It Worth Trying?


Journal

Reproductive sciences (Thousand Oaks, Calif.)
ISSN: 1933-7205
Titre abrégé: Reprod Sci
Pays: United States
ID NLM: 101291249

Informations de publication

Date de publication:
04 2019
Historique:
pubmed: 29 5 2018
medline: 24 12 2019
entrez: 29 5 2018
Statut: ppublish

Résumé

Due to several reasons, in some countries commercial oocyte donation is not possible. Accordingly, patients should find their own donors who may be over 35 years. The aim of this study was to compare the results of oocyte donation from donors <35 years (young donors) and donors ≥35 years old (older donors). A retrospective cohort study was conducted at a single academic reproductive center. We compared the results of oocyte donation from donors <35 years (345 cycles) and from donor ≥35 years old (83 cycles). We also performed subgroup analysis for single embryo transfer (SET) and fresh and frozen embryo transfers. Recipient demographic characteristics of the 2 groups were comparable. The age of the donors was 29.8 ± 3.9 years in the young donor group and 37.6 ± 2.1 years in the older donor group ( P < .0001). Pregnancy and implantation rates in the recipients from young donor group were statistically significantly higher than those from the older donor group (50.7% and 40.9% vs 38.3% and 23%; P = .04, P < .001). Cumulative pregnancy and live birth rates were significantly higher in the young donor group compared to the older donor group (86.1% vs 57.4% P < .0001 and 52.2% vs 33.3%, P = .02, respectively). Subgroup analysis showed comparable pregnancy and live birth rates for SET cycles (45.5% vs 40.4% and 25.0% vs 21.2%, respectively) and fresh cycles (54.7% vs 42.6% and 35.8% vs 29.6%, respectively). In nonanonymous oocyte donation programs, donation from older donors with good ovarian reserve is an acceptable approach when young donor is not available.

Identifiants

pubmed: 29806536
doi: 10.1177/1933719118776791
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

503-509

Auteurs

Tal Shavit (T)

1 Department of Obstetrics and Gynecology, McGill University, Montreal, Quebec, Canada.
2 Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Joseph Hasson (J)

1 Department of Obstetrics and Gynecology, McGill University, Montreal, Quebec, Canada.
2 Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Na'ama Al Ma'mari (N)

1 Department of Obstetrics and Gynecology, McGill University, Montreal, Quebec, Canada.

Weon-Yong Son (WY)

1 Department of Obstetrics and Gynecology, McGill University, Montreal, Quebec, Canada.

Ahmad Badeghiesh (A)

1 Department of Obstetrics and Gynecology, McGill University, Montreal, Quebec, Canada.

Tannus Samer (T)

1 Department of Obstetrics and Gynecology, McGill University, Montreal, Quebec, Canada.

Anat Klement-Hershko (A)

2 Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Amir Wiser (A)

2 Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Togas Tulandi (T)

1 Department of Obstetrics and Gynecology, McGill University, Montreal, Quebec, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH